# T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants

Giuseppe Gangarossa, Sophie Laffray, Emmanuel Bourinet, Emmanuel Valjent

► To cite this version:

Giuseppe Gangarossa, Sophie Laffray, Emmanuel Bourinet, Emmanuel Valjent. T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants. Frontiers in Behavioral Neuroscience, 2014, 8, pp.92. 10.3389/fnbeh.2014.00092. hal-01944937

HAL Id: hal-01944937

https://hal.science/hal-01944937

Submitted on 26 May 2021

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

# T-type calcium channel Ca<sub>v</sub>3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants

Giuseppe Gangarossa<sup>1,2,3*</sup>, Sophie Laffray<sup>1,2,3,4</sup>, Emmanuel Bourinet<sup>1,2,3,4</sup> and Emmanuel Valjent<sup>1,2,3*</sup>

**Edited by:**

Benjamin Adam Samuels, Columbia
University/Research Foundation for
Mental Hygeine, USA

**Reviewed by:**

Gerald Zamponi, University of Calgary,
Canada

Anjali M. Rajadhyaksha, Cornell
University Weill Medical College, USA
Tracey Petryshen, Massachusetts
General Hospital, USA

**\*Correspondence:**

Gangarossa Giuseppe and Valjent
Emmanuel, Institut de Génomique
Fonctionnelle, CNRS, UMR-5203,
INSERM U661, Montpellier F-34094,
France

e-mail: peppe.ganga@gmail.com;
emmanuel.valjent@gmail.com

The fine-tuning of neuronal excitability relies on a tight control of Ca<fnref n="2" />⁺ homeostasis. The low voltage-activated (LVA) T-type calcium channels (Ca<sub>v</sub>3.1, Ca<sub>v</sub>3.2 and Ca<sub>v</sub>3.3 isoforms) play a critical role in regulating these processes. Despite their wide expression throughout the central nervous system, the implication of T-type Ca<sub>v</sub>3.2 isoform in brain functions is still poorly characterized. Here, we investigate the effect of genetic ablation of this isoform in affective disorders, including anxiety, cognitive functions as well as sensitivity to drugs of abuse. Using a wide range of behavioral assays we show that genetic ablation of the *cacna1h* gene results in an anxiety-like phenotype, whereas novelty-induced locomotor activity is unaffected. Deletion of the T-type channel Ca<sub>v</sub>3.2 also triggers impairment of hippocampus-dependent recognition memories. Acute and sensitized hyperlocomotion induced by d-amphetamine and cocaine are dramatically reduced in T-type Ca<sub>v</sub>3.2 deficient mice. In addition, the administration of the T-type blocker TTA-A2 prevented the expression of locomotor sensitization observed in wildtype mice. In conclusion, our data reveal that physiological activity of this specific Ca<fnref n="2" />⁺ channel is required for affective and cognitive behaviors. Moreover, our work highlights the interest of T-type channel blockers as therapeutic strategies to reverse drug-associated alterations.

**Keywords:** T-type Ca<fnref n="2" />⁺ channels, anxiety, memory and learning, psychostimulants, drugs of abuse, spontaneous behavior

## INTRODUCTION

Affective and cognitive functions constitute a complex ensemble of behavioral skills strongly dependent on the fine regulation of intracellular homeostasis and neuronal excitability. The fine regulation of calcium (Ca<fnref n="2" />⁺) signaling is critical for basic neuronal functions including action potential generation, neurotransmitter release and synaptic plasticity (Berridge, 1998). Ca<fnref n="2" />⁺ is the most common signal transduction element in neurons and its entry is tightly regulated by two major classes of voltage-gated calcium channels (VGCCs): the high-voltage activated (HVA) (L-, P/Q and N-type) and the low-voltage activated (LVA) (T-type) calcium channels.

Three subtypes of T-type channel have been cloned, namely, Ca<sub>v</sub>3.1 (a1G), Ca<sub>v</sub>3.2 (a1H) and Ca<sub>v</sub>3.3 (a1I) (Cribbs et al., 1998, 2000; Lee et al., 1999; Zhuang et al., 2000; Gomora et al., 2002). T-type VGCCs are widely expressed throughout the body and, given their ability to switch neuronal firing patterns and modulate burst-firing activity in the central nervous system they have been implicated in several physiological aspects including sleep regulation, body weight maintenance and pain (Huguenard, 1996; Cribbs et al., 1998, 2000; Talley et al., 1999; Nilius et al., 2006; Bourinet et al., 2014). Disruption of calcium-dependent

low-threshold currents mediated by T-type calcium channels have been associated with a wide range of neurological and neuropsychiatric disorders including epilepsy, insomnia, Parkinson's disease, depression and schizophrenia as well as chronic pain syndromes (Huguenard and Prince, 1994; Kim et al., 2001, 2003; Anderson et al., 2005; Bourinet et al., 2005; Choi et al., 2007; Llinas et al., 2007; Uebele et al., 2009; Miwa et al., 2011; Francois et al., 2013; Park et al., 2013). Interestingly, several classes of drugs currently used in therapy (antipsychotics, antidepressants and antiepileptics) also show activity on T-type channels (Heady et al., 2001; Santi et al., 2002; Traboulsie et al., 2006; Kraus et al., 2007), thus suggesting T-type channels as a potential target for some brain dysfunctions. In addition, other calcium channel blockers including mibefradil, nicardipine, 2-octanol and amilodipine, which non-specifically act also on T-type channels, have been shown to reduce the psychomotor effects of cocaine, methamphetamine and phencyclidine (PCP; Popoli et al., 1993; Hori et al., 1998; Bisagno et al., 2010). More recently, the novel and specific blocker of T-type channels TTA-A2 has been reported to efficiently alleviate psychomotor effects induced by MK-801 and amphetamine as well as conditioned avoidance responding (Kraus et al., 2010; Uslaner et al., 2012), thus strengthening the

<footnote n="1"><sup>1</sup> Institut de Génomique Fonctionnelle, CNRS, UMR-5203, Montpellier, France</footnote>

<footnote n="2"><sup>2</sup> INSERM, U661, Montpellier, France</footnote>

<footnote n="3"><sup>3</sup> Universités de Montpellier 1 and 2, UMR-5203, Montpellier, France</footnote>

<footnote n="4"><sup>4</sup> Laboratories of Excellence, Ion Channel Science and Therapeutics, Institut de Génomique Fonctionnelle, Montpellier, France</footnote>
strategic interest of studying the T-type channels physiology and pharmacology.

Although the implication of T-type channels in neuronal excitability has been extensively studied (Nelson et al., 2006; Shin et al., 2008; Iftinca and Zamponi, 2009; Cheong and Shin, 2013), very little is known about the role of T-type channels in motor, affective and cognitive functions. Based on the fact that Ca₉.3.2 channels are widely expressed in the basal ganglia circuit, in limbic as well as in cortical areas (Talley et al., 1999) and that such circuits are critical components for the correct computation of many of these behaviors, we therefore decided to investigate the involvement of T-type Ca₉.3.2 channels in spontaneous and drugs-altered performances. Understanding the physiological role of T-type calcium channels has been for long time limited by the lack of selective pharmacological compounds (Perez-Reyes, 2003), but new T-type antagonists have recently been reported (Barrow et al., 2007; Shipe et al., 2008; Yang et al., 2008). In this study, we deciphered the implication of Ca₉.3.2 calcium channel in anxiety and memory disorders as well as in sensitivity to psychostimulants using Ca₉.3.2 deficient mice.

# MATERIALS AND METHODS

## ANIMALS

Ca₉.3.2 knockout mice (Chen et al., 2003) were maintained in the C57BL/6J background. Both WT and KO littermates were generated from Ca₉.3.2 heterozygous breeders. 8-12 weeks old male mice were used and maintained in a 12 h light/dark cycle, in stable conditions of temperature (22°C) and humidity (60%), with food and water *ad libitum*. All experiments were in accordance with the guidelines of the French Agriculture and Forestry Ministry for handling animals (D34-172-13).

## DRUGS

Cocaine hydrochloride (15 mg/kg, Sigma-Aldrich) and d-amphetamine sulfate (2 mg/kg, Sigma-Aldrich) were dissolved in 0.9% physiological saline and injected intraperitoneally (i.p.) in a body volume of 10 ml/kg. The T-type blocker TTA-A2 (1 mg/kg, p.o., Merck) was dissolved in a solution containing 0.05% methylcellulose in H₂O and 10% Tween80.

## LIGHT/DARK CONFLICT TEST

The light/dark conflict test, which is believed to measure anxiety-related behavior (Crawley and Goodwin, 1980), was performed by placing the mouse in a cage (35 cm width × 50 cm length × 20 cm height) that has two chambers, one bigger and bright (2/3), and the other smaller and dark (1/3). The animal was initially placed in the lighted side, and transitions between sides and the time spent in each division were recorded for 10 min. The apparatus was wiped with 70% ethanol between sessions.

## OPEN FIELD

Spontaneous exploratory behavior was monitored in an open field (white plastic arena with 35 cm width × 50 cm length × 20 cm height) for 10 min. The open field was wiped with 70% ethanol between sessions. The center zone was defined as a virtual perimeter within 5 cm from the sides of the arena. Experiments

were videotaped and an observer scored the time spent in the center (four paws inside the center zone) and the number of transitions in the center zone.

## ELEVATED-PLUS MAZE (EPM)

The elevated-plus maze (EPM) was elevated 1 m above the floor and was constructed of black plastic with 2 open arms (5 cm width × 35 cm length × 0.5 cm height of the walls) and two closed arms (5 cm width × 35 cm length × 15 cm height of the walls). Mice were placed in the center of an EPM facing one of the open arms and were allowed to explore the maze for 10 min. The EPM was wiped with 70% ethanol between sessions. Experiments were videotaped and scored for entries and time spent in the closed arms (four paws within closed arm) or open arms (four paws within open arms).

## ROTAROD TEST

Balance and motor coordination as well as motor learning were assessed using a mouse accelerating rotarod (Ugo Basile, Comerio, Italy). Mice were placed on the rotating drum that accelerated from 4 to 40 rpm over 5 min for four trials a day, for four consecutive days. The trial interval was 45 min for all the mice. Rotarod scores were scored for latency to either fall or ride the rod around.

## GRIP-STRENGTH TEST

The grip-strength apparatus (BioSeb, Chaville, France) comprised of a wire grid (8 × 8 cm) connected to an isometric force transducer (dynamometer). Mice were lifted by the tail so that their forepaws could grasp the grid. The mice were then gently pulled backward by the tail until the grid was released. The mean of three consecutive measurements for each mouse was calculated. The muscular strength was expressed in Newton (N) as mean ± SEM.

## HORIZONTAL GRID TEST

A cage grid is held at least 35 cm above a mouse cage containing 5-7 cm of soft bedding. Each hang period begins with all four paws of the mouse grasping the greed. The hang time is measured from the time the grid is inverted to the time that the mouse falls off the wire grid. A fixed limit of 60 s is applied for the hanging period.

## SPONTANEOUS AND DRUGS-INDUCED LOCOMOTOR ACTIVITY

Locomotor activity was measured as described previously (Brami-Cherrier et al., 2005; Gangarossa et al., 2013). Horizontal and vertical activity was measured in a circular corridor (Imetronic, Pessac, France). Counts for horizontal activity were incremented by consecutive interruption of two adjacent beams placed at a height of 1 cm per 90° sector of the corridor (mice moving through one-quarter of the circular corridor) and counts for vertical activity (rearings) as interruption of beams placed at a height of 7.5 cm along the corridor (mice stretching upwards). All mice were habituated to the test apparatus, handling, and procedure for three consecutive days before the actual experiment. In this habituation procedure mice were placed for 30 min in the activity box, received a first injection of saline, and were placed back in the box for 2 h. For the acute drug injection, the handling was
identical, except that the saline injection was replaced by adminis-
tration of cocaine (15 mg/kg, i.p.) and d-amphetamine (2 mg/kg,
i.p). In cocaine and amphetamine sensitization experiments, mice
were treated daily with cocaine (15 mg/kg, i.p.) and amphetamine
(2 mg/kg, i.p.) for five consecutive days. This repeated exposure
was followed by 8 days of withdrawal and by a challenge injection
of cocaine (15 mg/kg) or d-amphetamine (2 mg/kg). Locomotor
activity was measured as described above. The day after the
challenge, wildtype and Ca~v~3.2 deficient mice were treated with
TTA-A2 (1 mg/kg) or its vehicle 30 min prior the administration
of d-amphetamine or cocaine. The degree of psychostimulants-
induced locomotor sensitization was determined from the slope
of the curve corresponding to the 5 days of d-amphetamine or
cocaine administration.

SPONTANEOUS ALTERNATION Y-MAZE

The Y-maze apparatus, made of Plexiglas had three identical arms
(40 × 9 × 16 cm) placed at 120° with respect to each other.
Each mouse was placed at the end of one arm and allowed to
explore freely the apparatus for 5 min. Spontaneous alterna-
tion performance (SAP) was assessed by scoring the pattern of
entries into each arm during the 5 min of the test. Alternations
were defined as successive entries into each of the three arms
as on overlapping triplet sets (i.e., ABC, BCA, ...). Percent of
spontaneous alternations was defined as the ratio of actual (=
total alternations) to possible (= total arm entries –2) number
of alternations × 100. Total entries were scored as an index of
ambulatory activity in the Y-maze.

NOVEL OBJECT RECOGNITION (NOR)

Mice were habituated to a V-maze with two identical arms (34 × 6 × 15 cm, at 90°) for 10 min. The following day, mice were allowed to freely explore two objects (A and B) located at the end of the two arms. Object interaction was defined as approaching the object with the nose closer than 1 cm. Following a retention interval of 24 h, mice underwent a 5 min recall session during which the V-maze contained a familiar object (A) and a novel object (C). Following each session, the objects and the open field were cleaned with 70% ethanol. The experiments were videotaped and the time spent exploring the objects was scored. The percentage of exploration was calculated using the formula % exploration = ((Time C)/(Time A + Time C)) × 100.

SPATIAL OBJECT RECOGNITION (SOR)

Mice were habituated to an arena for 10 min. The following
day, mice were allowed to freely explore two different objects (A
and B) located in the same site of the arena. Object interaction
was defined as approaching the object with the nose closer than
1 cm. Following a retention interval of 24 h, mice underwent
a 5 min recall session during which the arena contained one of
the two objects displaced in the other site of the arena (novel
place). Following each session, the objects and the open field were
cleaned with 70% ethanol. The experiments were videotaped and
the time spent exploring the objects was scored. The percentage
of exploration was calculated using the formula % exploration =
((Time B)/(Time A + Time B)) × 100.

MARBLE BURYING

Mice were placed in the center of a clear plastic cage containing 5 cm of sawdust bedding with 24 glass marbles (1.5 cm diameter) on top, arranged in four rows of six marbles. The lid of the cage was used to prevent mice from escaping. Mice were then allowed to explore the testing chamber for 20 min. The number of marbles buried at least two-thirds deep were counted.

STATISTICS

The data were analyzed using one-way or two-way ANOVA
followed by Bonferroni *post-hoc* test for specific comparisons.
Student's *t*-test with equal variances was used for groups of two,
when relevant. In all cases, significance threshold was set at *p* <
0.05. Statistical analyses were performed using GraphPad Prism
5.0 (GraphPad Prism Software Inc., San Diego, USA).

RESULTS

NOVELTY-INDUCED SPONTANEOUS LOCOMOTOR ACTIVITY IS NOT  
IMPAIRED IN Ca~v~3.2 DEFICIENT MICE

We first investigated the spontaneous locomotor activity of Ca~v~3.2 deficient mice in response to novelty, in a non-stressful environment (low luminosity). No differences in the initial horizontal activity or in the habituation phase (3 days) were observed between WT and Ca~v~3.2 KO mice (Figures 1A–C), thus suggesting intact exploratory drive. In addition, despite a mild but significant attenuation in vertical locomotor activity (rearing behavior) observed in Ca~v~3.2 deficient mice during the first day (Figures 1D and E), both genotypes showed habituation to the testing environment (Figure 1F).

To investigate whether the genetic ablation of *Cacna1h* gene might induce muscular alteration that can ultimately impact on the spontaneous behavior of mice, we assessed muscular strength using two essays: the grip-strength and the grid test. Both tests revealed no major differences between genotypes. Grip-strength test: WT (1.68 N ± 0.076, *n* = 15) and KO (1.85 N ± 0.084, *n* = 14). Grid test: WT (59.87 sec ± 0.13, *n* = 15) and KO (59.79 sec ± 0.15, *n* = 14).

Taken together our results show that *Cacna1h* gene deletion does not alter spontaneous locomotor performance and exploratory drive.

Ca~v~3.2 DEFICIENT MICE SHOW ELEVATED ANXIETY

Because of the reduced vertical locomotor activity, we next
investigated anxiety-related behaviors in Ca~v~3.2 deficient mice
using well-established behavioral paradigms: the light/dark con-
flict context, the EPM and the open field tests. In the light/dark
test, KO mice spent less time in the light compartment and
more time in the dark compartment compared to WT mice
(Figure 2A). Ca~v~3.2 deficient mice were also slightly less active
than WT as demonstrated by the reduced number of entries in
both compartments (light and dark) (Figure 2B). In the EPM test,
Ca~v~3.2 deficient mice spent less time in the open arms compared
to their WT littermates confirming an increased anxiety-related
phenotype (Figure 2C). No differences were observed in the
number of entries in both closed and open arms suggesting that
this effect is not the result of an altered locomotor response
(Figure 2D). To further extend these behavioral observations, we
<figure><img src="image_3.png" /><figcaption>**FIGURE 1 |** Spontaneous locomotor activity in Ca,3.2 deficient mice. (A) Horizontal locomotor activity of Ca,3.2 null mice (n = 22) and their WT littermates (n = 26) in a novel non-stressful environment. Data (means ± SEM) were analyzed using two-way ANOVA: (Time × Genotype: *F*<sub>(14,644)</sub> = 1.607, *P* = 0.0724; Time: *F*<sub>(14,644)</sub> = 157.8, *P* < 0.0001; Genotype: *F*<sub>(1,46)</sub> = 0.0268, *P* = 0.8707). (B) Cumulative locomotor activity of WT and Ca,3.2 KO mice over a 150 min period. Data (means ± SEM) were analyzed using Student's t-test: NS. (C) Environmental habituation over a period of 3 days measured as a reduction of spontaneous horizontal locomotor activity. Data (means ± SEM) were analyzed using two-way ANOVA: (Time × Genotype: *F*<sub>(2,92)</sub> = 0.8412, *P* = 0.4345; Time: *F*<sub>(2,92)</sub> = 161.4, *P* < 0.0001; Genotype: *F*<sub>(1,46)</sub> = 0.9561, *P* = 0.3333). Specific comparisons: *** *p* < 0.001 (WT-Day3 vs. WT-Day1) and ** *p* < 0.001 (KO-Day3 vs. KO-Day1). (D) Rearing activity</figcaption></figure>

(vertical locomotor activity) of Ca,3.2 null mice (n = 22) and their WT littermates (n = 26) in a novel non-stressful environment. Data (means ± SEM) were analyzed using two-way ANOVA: (Time × Genotype: *F*<sub>(14,644)</sub> = 3.751, *P* < 0.0001; Time: *F*<sub>(14,644)</sub> = 70.86, *P* < 0.0001; Genotype: *F*<sub>(1,46)</sub> = 4.601, *P* = 0.0373). Specific comparisons: ** *p* < 0.01 and * *p* < 0.05 (KO vs. WT). (E) Cumulative rearing activity of WT and Ca,3.2 KO mice over a 150 min period. Data (means ± SEM) were analyzed using Student's t-test: * *p* < 0.05. (F) Environmental habituation over a period of 3 days measured as a reduction of spontaneous rearing activity. Data (means ± SEM) were analyzed using two-way ANOVA: (Time × Genotype: *F*<sub>(2,92)</sub> = 1.139, *P* = 0.3246; Time: *F*<sub>(2,92)</sub> = 76.78, *P* < 0.0001; Genotype: *F*<sub>(1,46)</sub> = 3.874, *P* = 0.05). Specific comparisons: *** *p* < 0.001 (WT-Day3 vs. WT-Day1), ** *p* < 0.001 (KO-Day3 vs. KO-Day1) and # *p* < 0.05 (KO-Day1 vs. WT-Day1).

measured the spontaneous behavior of Ca,3.2 deficient mice to explore a novel and stressful environment using the open field test. As shown in **Figure 2E**, Ca,3.2 deficient mice spent less time in the center of the arena compared to their WT littermates and made an equal number of transitions in the center zone compared to WT mice therefore indicating increased anxiety rather than a general locomotor deficit (**Figure 2F**).

Anxiety disorders are often exacerbated by repetitive and compulsive behaviors, such as in obsessive-compulsive disorder (OCD), in which abnormal repetitive behaviors can take place to alleviate recurrent and generalized anxiety. The marble burying test was then performed to assess whether Ca,3.2 null mice displayed some forms of compulsivity. No differences were observed in the number of marbles buried: WT (15.15 ± 1.5, *n* = 13) and KO (16.31 ± 0.5, *n* = 13).

Altogether these data strongly suggest that T-type Ca,3.2 channel influence anxiety-related behaviors, which do not seem being associated with repetitive and compulsive behaviors. Further studies should be performed to investigate whether T-type channels participate to altered behaviors observed in OCD.

## RECOGNITION MEMORY FUNCTIONS ARE DISRUPTED Ca,3.2 NULL MICE

Previous studies have shown that T-type Ca,3.2 is critical for hippocampal LTP, cued-context fear conditioning and passive avoidance tasks (Chen et al., 2012). We then investigated two hippocampal recognition memory tasks, the novel and the spatial object recognition (NOR and SOR, respectively). As shown in **Figures 3A, B**, Ca,3.2 deficient mice do not show preference for the novel or the relocated object during the recall session 24 h later as opposed to the WT. This altered response is not the result of an impairment of the exploratory drive since the exploration of the two objects is not significantly different from the WT animal during the familiarization phase (data not shown). Interestingly, the spatial working memory, assessed using the spontaneous alternation in the Y-Maze, was unaffected in Ca,3.2 deficient mice (**Figure 3C**).

Motor skill learning was also investigated in Ca,3.2 deficient mice using the accelerating rotarod. No differences were observed during the first day of rotarod training, thus suggesting unaltered motor coordination in Ca,3.2 deficient
<figure><img src="image_4.png" /></figure>

**FIGURE 2** | Anxiety-like behavior in Ca,3.2 deficient mice. Mice were tested in three anxiety-related behavioral paradigms: the ligh/dark conflict test, the elevated plus maze test (EPM) and the open field test. (A) Histograms show the percentage of time Ca,3.2 KO (n = 14) and WT mice (n = 15) spent in the light and the dark compartments. (B) Histograms indicate the number of entries of Ca,3.2 KO (n = 14) and WT mice (n = 15) in the light and the dark compartments. (A and B) Data (means ± SEM) were analyzed using Student's t-test: * *p* < 0.05; ** *p* < 0.01. (C) Histograms show the percentage of time Ca,3.2 KO (n = 17) and WT mice (n = 19) spent in the open arms of the EPM. Data (means ± SEM) were analyzed using Student's t-test: * *p* < 0.05. (D) Histograms indicate the number of entries of Ca,3.2 KO (n = 17) and WT mice (n = 19) in open and closed arms of EPM. Data (means ± SEM) were analyzed using student's t-test: ns. (E) Histograms show the percentage of time Ca,3.2 KO (n = 14) and WT mice (n = 15) spent in the center zone of the open field. Data (means ± SEM) were analyzed using student's t-test: * *p* < 0.05. (F) Histograms indicate the number of transitions Ca,3.2 KO (n = 14) and WT mice (n = 15) made in the center zone of the open field. Data (means ± SEM) were analyzed using student's t-test: ns.

mice (Figures 3D, E). Although Ca,3.2 KO mice showed a significant reduction of the motor performance compared to their WT littermates (Figures 3D, E), both genotypes

gradually acquired motor skills following extensive training (Figures 3D, E).

Altogether, these data strongly suggest that T-type Ca,3.2 channels influence preferentially memory recognition tasks, but spare working memory and motor learning.

## PSYCHOMOTOR EFFECTS OF D-AMPHETAMINE AND COCAINE ARE REDUCED IN Ca,3.2 DEFICIENT MICE

The psychomotor effects of cocaine, methamphetamine and PCP have been shown to partly involve the activity of T-type calcium channels (Popoli et al., 1993; Hori et al., 1998; Bisagno et al., 2010). To test the specific contribution of T-type Ca,3.2 channels in these locomotor responses, the acute hyperlocomotion induced by d-amphetamine (2 mg/kg, i.p.) and cocaine (15 mg/kg, i.p.) was evaluated in WT and Ca,3.2 deficient mice. As shown in Figure 4A, the total locomotor activity over a 120 min period induced by a single injection of d-amphetamine was dramatically reduced in Ca,3.2 deficient mice compared to their WT littermates. A similar effect was also observed when mice were treated with cocaine (Figure 4B).

We next determine whether Ca,3.2 KO mice could still undergo locomotor sensitization despite the reduced acute locomotor response. Repeated exposure to d-amphetamine (2 mg/kg) results in a progressive and persistent enhancement of the locomotor response in WT mice (Figure 4C). Ca,3.2 deficient mice also displayed locomotor sensitization but this response remained lower than in WT mice even when the mice were challenged after a withdrawal period of 8 days (Figure 4C). Interestingly, taking into account the slope sensitization, the locomotor sensitization to d-amphetamine was less pronounced in Ca,3.2 deficient mice than in their WT controls (Figure 4D). Similar results have been obtained when mice were repeatedly injected with cocaine (Figures 4E, F). Altogether, these results show that Ca,3.2 null mice displayed a reduction of sensitized responses to d-amphetamine and cocaine.

Finally, we examined whether a pharmacological acute blockade of T-type Ca²⁺ channel could affect the expression of locomotor sensitization in WT animals and therefore recapitulate the phenotype of Ca,3.2 null mice. To test this possibility, WT mice sensitized to d-amphetamine (Figures 5A-B) or cocaine (Figures 5D-E) were challenged with either vehicle or TTA-A2 (1 mg/kg, p.o.), a specific but non-selective T-type blocker prior to the last psychostimulant treatment (day 14). TTA-A2 blocked the expression of d-amphetamine and cocaine locomotor sensitization (Figures 5A, B, D, E). When the identical treatment regimen was performed in sensitized Ca,3.2 deficient mice, TTA-A2 had no effect on the expression of either d-amphetamine or cocaine locomotor sensitization (Figures 5A, C, D, F). Taken together, these results suggest that the effect of this T-type Ca²⁺ channel blocker on the expression of sensitization observed in WT mice was most likely attributable to the specific inhibition of the Ca,3.2 isoform.

## DISCUSSION

In the present study, we evaluate the effect of genetic ablation of the *Cacna1h* gene in several behavioral paradigms related to motor, affective and cognitive functions. T-type calcium channels
<figure><img src="image_5.png" /></figure>

**FIGURE 3 |** Memory functions in Ca,3.2 deficient mice. (A) Graph shows the percentage of exploration time of Ca,3.2 KO (n = 14) and WT (n = 15) mice in the NOR test. Data (means ± SEM) were analyzed using two-way ANOVA: (Object exploration × Genotype: *F*<sub>(1,44)</sub> = 25.80, *P* < 0.0001; Object exploration: *F*<sub>(1,44)</sub> = 37.58, *P* < 0.0001; Genotype: *F*<sub>(1,44)</sub> = 3.245e-014, *P* = 0.99). Specific comparisons: *** *p* < 0.001 (WT-new vs. WT-familiar). (B) Graph shows the percentage of exploration time of Ca,3.2 KO (n = 14) and WT (n = 15) mice in the SOR test. Data (means ± SEM) were analyzed using two-way ANOVA: (Object exploration × Genotype: *F*<sub>(1,44)</sub> = 31.80, *P* < 0.0001; Object exploration: *F*<sub>(1,44)</sub> = 48.81, *P* < 0.0001; Genotype: *F*<sub>(1,44)</sub> = 1.324e-013, *P* = 0.99). Specific comparisons: *** *p* < 0.001 (WT-new vs. WT-familiar). (C) Histogram indicates the percentage of spontaneous alternation of Ca,3.2 KO (n = 14) and WT (n = 15) in the

Y-maze test. The red dotted line represents the chance level of alternation (random, 50%). Data (means ± SEM) were analyzed using Student's t-test: ns. (D) Curves show coordination and motor learning in WT (n = 22) and Ca,3.2 KO (n = 22) mice over a training period of 4 days. Data (means ± SEM) were analyzed using two-way ANOVA (Time × Genotype: *F*<sub>(3,168)</sub> = 2.017, *P* = 0.1134; Time: *F*<sub>(3,168)</sub> = 19.03, *P* < 0.0001; Genotype: *F*<sub>(1,168)</sub> = 20.12, *P* < 0.0001). Specific comparisons: ** *p* < 0.01 (KO-Day4 vs. WT-Day4). (E) Percentage of motor learning in WT (n = 22) and Ca,3.2 KO (n = 22). Data (means ± SEM) were analyzed using two-way ANOVA (Time × Genotype: *F*<sub>(1,84)</sub> = 5.643, *P* < 0.05; Time: *F*<sub>(1,84)</sub> = 5.654, *P* < 0.05; Genotype: *F*<sub>(1,84)</sub> = 49.11, *P* < 0.0001). Specific comparisons: *** *p* < 0.001 (WT-Day4 vs. WT-Day1), ** *p* < 0.01 (KO-Day4 vs. KO-Day1) and ° *p* < 0.01 (KO-Day4 vs. WT-Day4).

mediate calcium-dependent low-threshold currents and they are
associated with rhythmic burst-firing activities of some brain
regions (Beurrier et al., 1999; Park et al., 2010; Tai et al., 2011;
Bourinet et al., 2014). By regulating Ca²⁺ homeostasis and neu-
ronal activation, T-type calcium channels (Ca,3.1, Ca,3.2 and
Ca,3.3) represent an interesting and promising pharmacological
target. T-type calcium channels are widely expressed in the brain
(Talley et al., 1999) and the T-type Ca,3.2 isoform is found in key
regions involved in affective and cognitive behaviors. However,
due to the lack of selective compounds for each T-type isoforms,
little is known about their respective specific implications in the
above-mentioned functions. Here, we focused on studying the T-
type Ca,3.2 channel using Ca,3.2 deficient mice. Our findings
reveal that the lack of *Cacna1h* gene promotes anxiety-related
behavior, impairs learning and memory formation and results in
a reduced sensitivity to psychostimulants (d-amphetamine and
cocaine).

The involvement of T-type calcium channels in anxiety-related
disorders is poorly documented. Our study reveals that mice
lacking the T-type Ca,3.2 showed elevated anxiety across a range
of behavioral tests including the light/dark conflict test, the EPM
and the open field. These phenotypes were not the result of a gen-
eral motor impairment since Ca,3.2 deficient showed unaltered
locomotor response when placed in a novel environment (see also
Choi et al., 2007). However, our results contrast with this previous
study reporting a lack of anxiety-related phenotype in Ca,3.2 KO
mice in the light/dark conflict test (Choi et al., 2007). Different
parameters could explain this apparent discrepancy. First, the
genetic background of the Ca,3.2 deficient mice employed in
both studies was different. While our mice were on a C57BL/6J
background the previous study used mice on a mixed 129/sv
and C57BL/6J background (Choi et al., 2007). C57BL/6 and 129
mouse lines are the most commonly used background strains in
research. However, these two strains show markedly differences in
<figure><img src="image_6.png" /></figure>

FIGURE 4 | Psychomotor effects of d-amphetamine and cocaine in Ca,3.2 deficient mice. (A) Locomotor activity induced by single administration of d-amphetamine (2 mg/kg, i.p.) in WT (n = 17) and Ca,3.2 KO (n = 15) mice. Data (means ± SEM) were analyzed using two-way ANOVA: (Treatment × Genotype: *F*(14,420) = 4.805, *P* < 0.0001; Treatment: *F*(14,420) = 8.34, *P* < 0.0001; Genotype: *F*(1,30) = 15.85, *P* < 0.001). (B) Locomotor activity induced by single administration of cocaine (15 mg/kg, i.p.) in WT (n = 9) and Ca,3.2 KO (n = 7) mice. Data (means ± SEM) were analyzed using two-way ANOVA: (Treatment × Genotype: *F*(14,196) = 12.09, *P* < 0.0001; Treatment: *F*(14,196) = 17.53, *P* < 0.0001; Genotype: *F*(1,14) = 20.92, *P* < 0.001). (C) Locomotor activity induced by repeated administration (sensitization protocol) of d-amphetamine (2 mg/kg, i.p.) in WT (n = 17) and Ca,3.2 KO (n = 15). Data (means ± SEM) were analyzed using two-way ANOVA: (Treatment × Genotype: *F*(6,210) = 5.280, *P* < 0.001; Treatment: *F*(6,210) = 43.34, *P* <

0.0001; Genotype: *F*(1,210) = 147.3, *P* < 0.001). Specific comparisons: *** *p* < 0.001 (KO vs. WT), ** *p* < 0.001 (WT-Day5 vs. WT-Day1) and # *p* < 0.01 (KO-Day5 vs. KO-Day1). (D) Degree of d-amphetamine-induced sensitization measured as a slope of sensitization curves in WT (n = 17) and Ca,3.2 KO (n = 15). Data (means ± SEM) were analyzed using Student's t-test: * *p* < 0.05. (E) Locomotor activity induced by repeated administration (sensitization protocol) of cocaine (15 mg/kg, i.p.) in WT (n = 9) and Ca,3.2 KO (n = 7). Data (means ± SEM) were analyzed using two-way ANOVA: (Treatment × Genotype: *F*(6,98) = 9.086, *P* < 0.0001; Treatment: *F*(6,98) = 37.96, *P* < 0.0001; Genotype: *F*(1,98) = 301.3, *P* < 0.0001). Specific comparisons: *** *p* < 0.001 (KO vs. WT), ** *p* < 0.001 (WT-Day5 vs. WT-Day1) and # *p* < 0.05 (KO-Day5 vs. KO-Day1). (F) Degree of cocaine-induced sensitization measured as a slope of sensitization curves in WT (n = 9) and Ca,3.2 KO (n = 7). Data (means ± SEM) were analyzed using Student's t-test: * *p* < 0.05.
<figure><img src="image_7.png" /></figure>

**FIGURE 5** | Effect of the T-type calcium channel inhibitor TTA-A2 on psychostimulants-induced locomotor activity. (A) Histograms show the effect of TTA-A2 (1 mg/kg, p.o.) on d-amphetamine-sensitized mice. Data (means ± SEM) were analyzed using two-way ANOVA: **A** (Treatment × Genotype: *F*<sub>(1,28)</sub> = 26.47, *P* < 0.0001; Treatment: *F*<sub>(1,28)</sub> = 2.595, *P* = 0.1185; Genotype: *F*<sub>(1,28)</sub> = 53.99, *P* < 0.0001). Specific comparisons: *** *P* < 0.001 (WT-TTA-A2+d-amph vs. WT-Veh+d-amph) and ** *P* < 0.001 (KO-Veh+d-amph vs. WT-Veh+d-amph). (B and C) Curves showing the behavioral profile of T-type channels blocker TTA-A2 in WT (B, *n* = 9) and Ca,3.2 KO (C, *n* = 7) d-amphetamine-treated mice. Data (means ± SEM) were analyzed using two-way ANOVA: **B** (Treatment × Time: *F*<sub>(14,224)</sub> = 9.302, *P* < 0.0001; Time: *F*<sub>(14,224)</sub> = 34.60, *P* < 0.0001; Treatment: *F*<sub>(1,16)</sub> = 83.58, *P* < 0.0001); **C** (Treatment × Time: *F*<sub>(14,168)</sub> = 2.717, *P* < 0.01; Time:

*F*<sub>(14,168)</sub> = 85.72, *P* < 0.0001; Treatment: *F*<sub>(1,12)</sub> = 2.108, *P* = 0.1722). (D) Histograms show the effect of TTA-A2 (1 mg/kg, p.o.) on cocaine-sensitized mice. Data (means ± SEM) were analyzed using two-way ANOVA: **A** (Treatment × Genotype: *F*<sub>(1,28)</sub> = 24.15, *P* < 0.0001; Treatment: *F*<sub>(1,28)</sub> = 27.96, *P* < 0.0001; Genotype: *F*<sub>(1,28)</sub> = 34.54, *P* < 0.0001). Specific comparisons: *** *P* < 0.001 (WT-TTA-A2+Coc vs. WT-Veh+Coc) and ** *P* < 0.001 (KO-Veh+Coc vs. WT-Veh+Coc). (E and F) Curves showing the behavioral profile of T-type calcium channels blocker TTA-A2 in WT (E, *n* = 9) and Ca,3.2 KO (F, *n* = 7) cocaine-treated mice. Data (means ± SEM) were analyzed using two-way ANOVA: **E** (Treatment × Time: *F*<sub>(14,224)</sub> = 2.31, *P* < 0.01; Time: *F*<sub>(14,224)</sub> = 37.34, *P* < 0.0001; Treatment: *F*<sub>(1,16)</sub> = 50.35, *P* < 0.0001); **F** (Treatment × Time: *F*<sub>(14,168)</sub> = 1.768, *P* < 0.05; Time: *F*<sub>(14,168)</sub> = 29.27, *P* < 0.0001; Treatment: *F*<sub>(1,12)</sub> = 0.8157, *P* = 0.3842).

learning and memory, anxiety and sensitivity to drugs (Humanics et al., 1999; Contet et al., 2001; Cook et al., 2001, 2002; Murphy et al., 2001; Bouwknecht and Paylor, 2002). It is worth to mention that, in the light/dark conflict test, C57BL/6 show higher transition frequency and reduced time in the dark compartment compared to the 129 mouse line (Bouwknecht and Paylor, 2002).

The second aspect is related to the behavioral procedure used to perform the light/dark conflict test. In the present study, mice were always placed in the light compartment at the beginning of the session (Crawley and Goodwin, 1980; Gao and Cutler, 1992; Bourin and Hascoët, 2003). This contrasts with the study of Choi and colleagues and could explain why different results have been
observed between the two studies (Choi et al., 2007). Further-
more, the behavioral responses we observed in the EPM and the
open field test strongly support an implication of Ca<sub>v</sub>3.2 T-type
calcium channels in anxiety-related behaviors. Even though our
results suggest that the anxious phenotype observed in KO mice
is not associated with repetitive behavior, a study clearly aiming
at deciphering the role of T-type calcium channels in OCD-like
behavior need to be undertaken.

Calcium-dependent signaling is important for LTP and learning and memory functions. NMDA-independent influx of Ca²⁺ through VGCCs has been shown to be crucial for both hippocampus- and amygdala-dependent tasks. Thus, HVA L-type Ca_v1.2 and Ca_v1.3 mutant mice showed altered spatial memory and impaired consolidation of fear conditioning, respectively (Moosmang et al., 2005; McKinney and Murphy, 2006; White et al., 2008). In addition, ablation of HVA P/Q-type Ca²⁺ channels impaired memory functions (Mallmann et al., 2013). Interestingly, disruption of the T-type calcium channel activity has been reported to strongly alter physiological induction and maintenance of LTP in the hippocampus, visual cortex and cerebellum (Yoshimura et al., 2008; Chen et al., 2012; Ly et al., 2013) and mutations of the human *caca1h* gene have been associated with autism spectrum disorder (ASD; Splawski et al., 2006). Moreover, the demonstration that T-type calcium channels are interacting with the neurotransmitter release machinery reinforces the notion of their impact on synaptic transmission (Tang et al., 2011; Weiss et al., 2012a,b). Our study further highlights the emerging role of Ca_v3.2 channels in learning and memory functions. Thus, while the working memory function is spared, memory recognition assessed by using the NOR and SOR is strongly impaired in Ca_v3.2 deficient mice. This impairment is not the result of a deficit of exploratory drive since Ca_v3.2 null mice and WT animals showed similar object exploration during the familiarization phases of the two behavioral tasks. In contrast, in the Morris water maze, memory formation and retrieval are not altered in Ca_v3.2 deficient mice (Chen et al., 2012). In addition, we also found that, although less efficient, Ca_v3.2 null mice were able to acquired motor skills suggesting the neural systems involved in these processes are functional. Altogether these functional data strongly suggest that T-type Ca_v3.2 channels influence a subset of specific learning and memory processes.

The contribution of VGCCs in the action of psychostimu-
lant drugs has been extensively documented (Karler et al., 1991;
Ansah et al., 1993; Schechter, 1993; Pierce and Kalivas, 1997;
Pierce et al., 1998; Licata et al., 2000; Newton et al., 2004, 2008;
Rajadhyaksha and Kosofsky, 2005; Chartoff et al., 2006; Bisagno
et al., 2010; Giordano et al., 2010). However, little is known about
the contribution of T-type calcium channels. Here, we found
that T-type Ca_v3.2 channels are necessary for acute psychomotor
effects induced by cocaine and d-amphetamine. These data extend
previous results obtained in rats showing that the pharmacologi-
cal blockade of T-type calcium channels achieved with TTA-A2,
strongly reduced d-amphetamine-induced psychomotor effects
(Bisagno et al., 2010; Uslaner et al., 2012). Interestingly, this initial
study suggested that this effect would result from an alteration of
the glutamatergic transmission since TTA-A2 inhibits glutamate
release in the nucleus accumbens leaving unaltered dopamine

influx (Uslaner et al., 2012). However, functional coupling of T-
type currents to calcium-activated-potassium channels has been
proposed to modify firing pattern of midbrain DA neurons
(Wolfart and Roeper, 2002), a mechanism that may contribute to
reward-based processes.

Our study also highlights that T-type Ca<sub>v</sub>3.2 channels par-
ticipate to psychostimulant-induced development and expression
of drug sensitization. Interestingly, previous studies pointed out
that Ca<sub>v</sub>1.3 L-type calcium channels (LTCCs) mediate develop-
ment of sensitization whereas Ca<sub>v</sub>1.2 LTCCs mediate expression
of the psychostimulant-induced sensitized response (Giordano
et al., 2010). Furthermore, our pharmacological experiment,
using TTA-A2, strongly suggests that the Ca<sub>v</sub>3.2 channel is the
only member of the T-type family required for the expression
of sensitization, a crucial finding for future relevance in clinical
treatments of addictions. Given the high expression of Ca<sub>v</sub>3.2
mRNA in the striatum, the nucleus accumbens and other nuclei
that composed the rewarding systems (Talley et al., 1999), it is
tempting to speculate that the effects observed are associated with
altered functions of this T-type isoform within the circuit. Future
experiments are necessary to identify whether the altered acute
responses are associated with the function of the Ca<sub>v</sub>3.2 channel
in a particular cell-type of the system mentioned above.

Follow up explorations would be needed in the next future
to precise the cellular basis of the underlying circuits involved,
especially when cell and tissue specific conditional knockout
mice will be available. Moreover, elucidation of the cellular and
subcellular Ca<sub>v</sub>3.2 expression patterns is still pending to the avail-
ability of faithful antibodies. We should also mention that brain
regions (i.e., cortex, hippocampus, striatum, midbrain) known to
be important for the behaviors here explored express high level
of Ca<sub>v</sub>3.2 transcripts (Talley et al., 1999), and that functional
presence of Ca<sub>v</sub>3.2 like T-type currents is well established in these
regions (Perez-Reyes, 2003).

Our study shows that T-type Ca<sub>v</sub>3.2 calcium channels are strongly involved in affective and cognitive functions. In depth behavioral characterization of Ca<sub>v</sub>3.2 deficient mice revealed an anxiety-like phenotype although general exploratory drive was unaltered. We further demonstrate an impairment of recognition memory functions but intact working memory processing in Ca<sub>v</sub>3.2-ablated mice. In addition, we also provide evidence for an involvement of specific T-type Ca<sub>v</sub>3.2 calcium channels in sensitization processes triggered by commonly abused psychostimulant drugs.

However, it should be mentioned that mechanisms of func-
tional compensations by other T-type calcium channels might
occur due to global knockout of Ca<sub>v</sub>3.2 although no compensa-
tion in Ca<sub>v</sub>3.1 and Ca<sub>v</sub>3.3 has been detected at the level of the
hippocampus (see GEO<fnref n="1" />).

In conclusion, our data highlight that physiological activity
of the specific T-type Ca<sub>v</sub>3.2 calcium channel is required for
affective and cognitive behaviors suggesting potential functional
implications of this calcium channel in many brain disorders.
The emergence of T-type selective pharmacology is therefore very
promising and holds many clinical perspectives.

<footnote n="1">¹www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30846</footnote>
ACKNOWLEDGMENTS

We are grateful to Dr. V. Uebele (Merck and Co., Inc.) for the TTA-A2 molecule. This work was supported by Inserm and grants from ATIP-Avenir (Inserm), Sanofi-Aventis R and D, from the Agence Nationale de la Recherche (ANR-2010-JCJC-1412) to Valjent Emmanuel, and by grants from the ANR (ANR-09-MNPS-037) and the AFM (AFM-PainT) to Bourinet Emmanuel. Laffray Sophie is supported by fellowships from the FRM and the Labex ICST.

REFERENCES

Anderson, M. P., Mochizuki, T., Xie, J., Fischler, W., Manger, J. P., Talley, E. M., et al. (2005). Thalamic Cav3.1 T-type Ca2+ channel plays a crucial role in stabilizing sleep. *Proc. Natl. Acad. Sci. U S A* 102, 1743–1748. doi: 10.1073/pnas.0409644102

Ansah, T. A., Wade, L. H., and Shockley, D. C. (1993). Effects of calcium channel entry blockers on cocaine and amphetamine-induced motor activities and toxicities. *Life Sci.* 53, 1947–1956. doi: 10.1016/0024-3205(93)90016-v

Barrow, J. C., Bieber, K. A. S., Cube, R. V., Mattern, M. C., Reger, T. S., Shu, Y., et al. (2007). *Pyridyl amide T-type calcium channels*. http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2007120729&recNum=24&docAn=U S2007008977&queryString=%28IN%2522Barrow,%2520James%2522%29% 2520&maxRec=52

Berridge, M. J. (1998). Neuronal calcium signaling. *Neuron* 21, 13–26. doi: 10.1016/S0896-6273(00)80510-3

Beurrier, C., Congar, P., Bioulac, B., and Hammond, C. (1999). Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode. *J. Neurosci.* 19, 599–609.

Bisagno, V., Raineri, M., Peskin, V., Wikinski, S. I., Uchitel, O. D., Llinas, R. R., et al. (2010). Effects of T-type calcium channel blockers on cocaine-induced hyperlocomotion and thalamocortical GABAergic abnormalities in mice. *Psychopharmacology* (Berl) 212, 205–214. doi: 10.1007/s00213-010-1947-z

Bourin, M., and Hascoët, M. (2003). The mouse light/dark box test. *Eur. J. Pharmacol.* 463, 55–65. doi: 10.1016/s0014-2999(03)01274-3

Bourinet, E., Alloui, A., Monteil, A., Barrere, C., Couette, B., Poirot, O., et al. (2005). Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. *EMBO J.* 24, 315–324. doi: 10.1038/sj.emboj.7600515

Bourinet, E., Altier, C., Hildebrand, M. E., Trang, T., Salter, M. W., and Zamponi, G. W. (2014). Calcium-permeable ion channels in pain signaling. *Physiol. Rev.* 94, 81–140. doi: 10.1152/physrev.00023.2013

Bouwknecht, J. A., and Paylor, R. (2002). Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains. *Behav. Brain Res.* 136, 489–501. doi: 10.1016/s0166-4328(02)00200-0

Brami-Cherrier, K., Valjent, E., Herve, D., Darragh, J., Corvol, J. C., Pages, C., et al. (2005). Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice. *J. Neurosci.* 25, 11444–11454. doi: 10.1523/jneurosci.1711-05.2005

Chartoff, E. H., Pliakas, A. M., and Carlezon, W. A. Jr. (2006). Microinjection of the L-type calcium channel antagonist diltiazem into the ventral nucleus accumbens shell facilitates cocaine-induced conditioned place preferences. *Biol. Psychiatry* 59, 1236–1239. doi: 10.1016/j.biopsych.2005.09.024

Chen, C. C., Lamping, K. G., Nuno, D. W., Barresi, R., Prouty, S. J., Lavoie, J. L., et al. (2003). Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels. *Science* 302, 1416–1418. doi: 10.1126/science.1089268

Chen, C. C., Shen, J. W., Chung, N. C., Min, M. Y., Cheng, S. J., and Liu, I. Y. (2012). Retrieval of context-associated memory is dependent on the Ca(v)3.2 T-type calcium channel. *PLoS One* 7:e29384. doi: 10.1371/journal.pone.0029384

Cheong, E., and Shin, H. S. (2013). T-type Ca2+ channels in normal and abnormal brain functions. *Physiol. Rev.* 93, 961–992. doi: 10.1152/physrev.00010.2012

Choi, S., Na, H. S., Kim, J., Lee, J., Lee, S., Kim, D., et al. (2007). Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels. *Genes Brain Behav.* 6, 425–431. doi: 10.1111/j.1601-183x.2006.00268.x

Contet, C., Rawlins, J. N., and Deacon, R. M. (2001). A comparison of 129S2/SvHsd and C57BL/6JolaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice. *Behav. Brain Res.* 124, 33–46. doi: 10.1016/s0166-4328(01)00231-5

Cook, M. N., Bolivar, V. J., McFadyen, M. P., and Flaherty, L. (2002). Behavioral differences among 129 substrains: implications for knockout and transgenic mice. *Behav. Neurosci.* 116, 600–611. doi: 10.1037/0735-7044.116.4.600

Cook, M. N., Williams, R. W., and Flaherty, L. (2001). Anxiety-related behaviors in the elevated zero-maze are affected by genetic factors and retinal degeneration. *Behav. Neurosci.* 115, 468–476. doi: 10.1037//0735-7044.115.2.468

Crawley, J., and Goodwin, F. K. (1980). Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. *Pharmacol. Biochem. Behav.* 13, 167–170. doi: 10.1016/0091-3057(80)90067-2

Cribbs, L. L., Gomora, J. C., Daud, A. N., Lee, J. H., and Perez-Reyes, E. (2000). Molecular cloning and functional expression of Ca(v)3.1c, a T-type calcium channel from human brain. *FEBS Lett.* 466, 54–58. doi: 10.1016/s0014-5793(99)01756-1

Cribbs, L. L., Lee, J. H., Yang, J., Satin, J., Zhang, Y., Daud, A., et al. (1998). Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family. *Circ. Res.* 83, 103–109. doi: 10.1161/01.res.83.1.103

Francois, A., Kerckhove, N., Meleine, M., Alloui, A., Barrere, C., Gelot, A., et al. (2013). State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects. *Pain* 154, 283–293. doi: 10.1016/j.pain.2012.10.023

Gangarossa, G., Perroy, J., and Valjent, E. (2013). Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum. *Brain Struct. Funct.* 218, 405–419. doi: 10.1007/s00429-012-0405-6

Gao, B., and Cutler, M. G. (1992). Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage. *Neuropharmacology* 31, 743–748. doi: 10.1016/0028-3908(92)90035-n

Giordano, T. P., Tropea, T. F., Satpute, S. S., Sinnegger-Brauns, M. J., Striessnig, J., Kosofsky, B. E., et al. (2010). Molecular switch from L-type Ca v 1.3 to Ca v 1.2 Ca2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity. *J. Neurosci.* 30, 17051–17062. doi: 10.1523/JNEUROSCI.2255-10.2010

Gomora, J. C., Murbartian, J., Arias, J. M., Lee, J. H., and Perez-Reyes, E. (2002). Cloning and expression of the human T-type channel Ca(v)3.3: insights into prepulse facilitation. *Biophys. J.* 83, 229–241. doi: 10.1016/s0006-3495(02)75164-3

Heady, T. N., Gomora, J. C., Macdonald, T. L., and Perez-Reyes, E. (2001). Molecular pharmacology of T-type Ca2+ channels. *Jpn. J. Pharmacol.* 85, 339–350. doi: 10.1254/jjp.85.339

Homanics, G. E., Quinlan, J. J., and Firestone, L. L. (1999). Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines. *Pharmacol. Biochem. Behav.* 63, 21–26. doi: 10.1016/s0091-3057(98)00232-9

Hori, Y., Takeda, H., Tsuji, M., and Matsumiya, T. (1998). Differentiation of the inhibitory effects of calcium antagonists on abnormal behaviors induced by methamphetamine or phencyclidine. *Pharmacology* 56, 165–174. doi: 10.1159/000028195

Huguenard, J. R. (1996). Low-threshold calcium currents in central nervous system neurons. *Annu. Rev. Physiol.* 58, 329–348. doi: 10.1146/annurev.physiol.58.1.329

Huguenard, J. R., and Prince, D. A. (1994). Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects. *J. Neurosci.* 14, 5485–5502.

Iftinca, M. C., and Zamponi, G. W. (2009). Regulation of neuronal T-type calcium channels. *Trends Pharmacol. Sci.* 30, 32–40. doi: 10.1016/j.tips.2008.10.004

Karler, R., Turkanis, S. A., Partlow, L. M., and Calder, L. D. (1991). Calcium channel blockers and behavioral sensitization. *Life Sci.* 49, 165–170. doi: 10.1016/0024-3205(91)90029-b

Kim, D., Park, D., Choi, S., Lee, S., Sun, M., Kim, C., et al. (2003). Thalamic control of visceral nociception mediated by T-type Ca2+ channels. *Science* 302, 117–119. doi: 10.1126/science.1088886
Kim, D., Song, I., Um, S., Lee, T., Jeong, M. J., Kim, S. S., et al. (2001). Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels. *Neuron* 31, 35–45. doi: 10.1016/S0896-6273(01)00343-9

Kraus, R. L., Li, Y., Gregan, Y., Gotter, A. L., Uebele, V. N., Fox, S. V., et al. (2010). In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice. *J. Pharmacol. Exp. Ther.* 335, 409–417. doi: 10.1124/jpet.110.171058

Kraus, R. L., Li, Y., Jovanovska, A., and Renger, J. J. (2007). Trazodone inhibits T-type calcium channels. *Neuropharmacology* 53, 308–317. doi: 10.1016/j.neuropharm.2007.05.011

Lee, J. H., Daud, A. N., Cribbs, L. L., Lacerda, A. E., Pereverzev, A., Klockner, U., et al. (1999). Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family. *J. Neurosci.* 19, 1912–1921.

Licata, S. C., Freeman, A. Y., Pierce-Bancroft, A. F., and Pierce, R. C. (2000). Repeated stimulation of L-type calcium channels in the rat ventral tegmental area mimics the initiation of behavioral sensitization to cocaine. *Psychopharmacology (Berl)* 152, 110–118. doi: 10.1007/s002130000518

Llinas, R. R., Choi, S., Urbano, F. J., and Shin, H. S. (2007). Gamma-band deficiency and abnormal thalamocortical activity in P/Q-type channel mutant mice. *Proc. Natl. Acad. Sci. U S A* 104, 17819–17824. doi: 10.1073/pnas.0707945104

Ly, R., Bouvier, G., Schonewille, M., Arabo, A., Rondi-Reig, L., Lena, C., et al. (2013). T-type channel blockade impairs long-term potentiation at the parallel fiber-Purkinje cell synapse and cerebellar learning. *Proc. Natl. Acad. Sci. U S A* 110, 20302–20307. doi: 10.1073/pnas.1311686110

Mallmann, R. T., Elgueta, C., Sleman, F., Castonguay, J., Wilmes, T., Van Den Maagdenberg, A., et al. (2013). Ablation of CaV2.1 voltage-gated Ca(2+) channels in mouse forebrain generates multiple cognitive impairments. *PLoS One* 8:e78598. doi: 10.1371/journal.pone.0078598

McKinney, B. C., and Murphy, G. G. (2006). The L-Type voltage-gated calcium channel Cav1.3 mediates consolidation, but not extinction, of contextually conditioned fear in mice. *Learn. Mem.* 13, 584–589. doi: 10.1101/lm.279006

Miwa, H., Koh, J., Kajimoto, Y., and Kondo, T. (2011). Effects of T-type calcium channel blockers on a parkinsonian tremor model in rats. *Pharmacol. Biochem. Behav.* 97, 656–659. doi: 10.1016/j.pbb.2010.11.014

Moosmang, S., Haider, N., Klugbauer, N., Adelsberger, H., Langwieser, N., Muller, J., et al. (2005). Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. *J. Neurosci.* 25, 9883–9892. doi: 10.1523/jneurosci.1531-05.2005

Murphy, N. P., Lam, H. A., and Maidment, N. T. (2001). A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice. *J. Neurochem.* 79, 626–635. doi: 10.1046/j.1471-4159.2001.00599.x

Nelson, M. T., Todorovic, S. M., and Perez-Reyes, E. (2006). The role of T-type calcium channels in epilepsy and pain. *Curr. Pharm. Des.* 12, 2189–2197. doi: 10.2174/138161206777585184

Newton, P. M., Orr, C. J., Wallace, M. J., Kim, C., Shin, H. S., and Messing, R. O. (2004). Deletion of N-type calcium channels alters ethanol reward and reduces ethanol consumption in mice. *J. Neurosci.* 24, 9862–9869. doi: 10.1523/jneurosci.3446-04.2004

Newton, P. M., Zeng, L., Wang, V., Connolly, J., Wallace, M. J., Kim, C., et al. (2008). A blocker of N- and T-type voltage-gated calcium channels attenuates ethanol-induced intoxication, place preference, self-administration and reinstatement. *J. Neurosci.* 28, 11712–11719. doi: 10.1523/JNEUROSCI.3621-08.2008

Nilius, B., Talavera, K., and Verkratsky, A. (2006). T-type calcium channels: the never ending story. *Cell Calcium* 40, 81–88. doi: 10.1016/j.ceca.2006.04.011

Park, Y. G., Kim, J., and Kim, D. (2013). The potential roles of T-type Ca2+ channels in motor coordination. *Front. Neural Circuits* 7:172. doi: 10.3389/fncir.2013.00172

Park, Y. G., Park, H. Y., Lee, C. J., Choi, S., Jo, S., Choi, H., et al. (2010). Ca(V)3.1 is a tremor rhythm pacemaker in the inferior olive. *Proc. Natl. Acad. Sci. U S A* 107, 10731–10736. doi: 10.1073/pnas.1002995107

Perez-Reyes, E. (2003). Molecular physiology of low-voltage-activated t-type calcium channels. *Physiol. Rev.* 83, 117–161. doi: 10.1152/physrev.00018.2002

Pierce, R. C., and Kalivas, P. W. (1997). Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. *J. Neurosci.* 17, 3254–3261.

Pierce, R. C., Quick, E. A., Reeder, D. C., Morgan, Z. R., and Kalivas, P. W. (1998). Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. *J. Pharmacol. Exp. Ther.* 286, 1171–1176.

Popoli, P., Pezzola, A., and Scotti de Carolis, A. (1993). Influence of non-L-type calcium channel antagonists on phencyclidine-induced effects in rats. *Life Sci.* 52, 2055–2061. doi: 10.1016/0024-3205(93)90690-5

Rajadhyaksha, A. M., and Kosofsky, B. E. (2005). Psychostimulants, L-type calcium channels, kinases and phosphatases. *Neuroscientist* 11, 494–502. doi: 10.1177/1073858405278236

Santi, C. M., Cayabyab, F. S., Sutton, K. G., Mcrory, J. E., Mezeyova, J., Hamming, K. S., et al. (2002). Differential inhibition of T-type calcium channels by neuroleptics. *J. Neurosci.* 22, 396–403.

Schechter, M. D. (1993). Cocaine discrimination is attenuated by isradipine and CGS 10746B. *Pharmacol. Biochem. Behav.* 44, 661–664. doi: 10.1016/0091-3057(93)90183-t

Shin, H. S., Cheong, E. J., Choi, S., Lee, J., and Na, H. S. (2008). T-type Ca2+ channels as therapeutic targets in the nervous system. *Curr. Opin. Pharmacol.* 8, 33–41. doi: 10.1016/j.coph.2007.12.003

Shipe, W. D., Barrow, J. C., Yang, Z. Q., Lindsley, C. W., Yang, F. V., Schlegel, K. A., et al. (2008). Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist. *J. Med. Chem.* 51, 3692–3695. doi: 10.1021/jm800419w

Splatowski, I., Yoo, D. S., Stotz, S. C., Cherryl, A., Clapham, D. E., and Keating, M. T. (2006). CACNA1H mutations in autism spectrum disorders. *J. Biol. Chem.* 281, 22085–22091. doi: 10.1074/jbc.m603316200

Tai, C. H., Yang, Y. C., Pan, M. K., Huang, C. S., and Kuo, C. C. (2011). Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease. *J. Clin. Invest.* 121, 3289–3305. doi: 10.1172/JCI46482

Talley, E. M., Cribbs, L. L., Lee, J. H., Daud, A., Perez-Reyes, E., and Bayliss, D. A. (1999). Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. *J. Neurosci.* 19, 1895–1911.

Tang, A. H., Karson, M. A., Nagode, D. A., Mcintosh, J. M., Uebele, V. N., Renger, J. J., et al. (2011). Nerve terminal nicotinic acetylcholine receptors initiate quantal GABA release from perisomatic interneurons by activating axonal T-type (Cav3) Ca(2)(+) channels and Ca(2)(+) release from stores. *J. Neurosci.* 31, 13546–13561. doi: 10.1523/JNEUROSCI.2781-11.2011

Traboulsie, A., Chemin, J., Kupfer, E., Nargeot, J., and Lory, P. (2006). T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. *Mol. Pharmacol.* 69, 1963–1968. doi: 10.1124/mol.105.020842

Uebele, V. N., Gotter, A. L., Nuss, C. E., Kraus, R. L., Doran, S. M., Garson, S. L., et al. (2009). Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in mice. *J. Clin. Invest.* 119, 1659–1667. doi: 10.1172/JCI36954

Uslaner, J. M., Smith, S. M., Huszar, S. L., Pachmerhiwala, R., Hinchliffe, R. M., Vardigan, J. D., et al. (2012). T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats. *Neuropharmacology* 62, 1413–1421. doi: 10.1016/j.neuropharm.2010.11.015

Weiss, N., Hameed, S., Fernandez-Fernandez, J. M., Fablet, K., Karmazinova, M., Poillot, C., et al. (2012a). A Ca(v)3.2/syntaxin-1A signaling complex controls T-type channel activity and low-threshold exocytosis. *J. Biol. Chem.* 287, 2810–2818. doi: 10.1074/jbc.M111.290882

Weiss, N., Zamponi, G. W., and De Waard, M. (2012b). How do T-type calcium channels control low-threshold exocytosis? *Commun. Integr. Biol.* 5, 377–380. doi: 10.4161/cib.19997

White, J. A., Mckinney, B. C., John, M. C., Powers, P. A., Kamp, T. J., and Murphy, G. G. (2008). Conditional forebrain deletion of the L-type calcium channel Ca V 1.2 disrupts remote spatial memories in mice. *Learn. Mem.* 15, 1–5. doi: 10.1101/lm.773208

Wolfart, J., and Roeper, J. (2002). Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons. *J. Neurosci.* 22, 3404–3413.

Yang, Z. Q., Barrow, J. C., Shipe, W. D., Schlegel, K. A., Shu, Y., Yang, F. V., et al. (2008). Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels. *J. Med. Chem.* 51, 6471–6477. doi: 10.1021/jm800830n

Yoshimura, Y., Inaba, M., Yamada, K., Kurotani, T., Begum, T., Reza, F., et al. (2008). Involvement of T-type Ca2+ channels in the potentiation of synaptic and visual
responses during the critical period in rat visual cortex. *Eur. J. Neurosci.* 28, 730–743. doi: 10.1111/j.1460-9568.2008.06384.x

Zhuang, H., Bhattacharjee, A., Hu, F., Zhang, M., Goswami, T., Wang, L., et al. (2000). Cloning of a T-type Ca2+ channel isoform in insulin-secreting cells. *Diabetes* 49, 59–64. doi: 10.2337/diabetes.49.1.59

**Conflict of Interest Statement:** The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.

Received: 15 January 2014; accepted: 03 March 2014; published online: 18 March 2014.

Citation: Gangarossa G, Laffray S, Bourinet E and Valjent E (2014) T-type calcium channel Ca₃.₂ deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants. *Front. Behav. Neurosci.* 8:92. doi: 10.3389/fnbeh.2014.00092

This article was submitted to the journal *Frontiers in Behavioral Neuroscience*.

Copyright © 2014 Gangarossa, Laffray, Bourinet and Valjent. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permit-
ted, provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.

No use, distribution or reproduction is permitted which does not comply with these
terms.